Uncovering molecular mechanisms for amelanotic/hypopigmented primary cutaneous melanoma
- Author(s)
- Sturm, RA; Smit, DJ; Duffy, DL; McLean, C; Scolyer, RA; McArthur, GA; Papenfuss, AT; Stark, MS; Soyer, HP; Mar, VJ;
- Journal Title
- British Journal of Dermatology
- Publication Type
- 21 Aug epub ahead of print
- Abstract
- BACKGROUND: A portion of approximately 2-20% of cutaneous melanoma (CM) are diagnosed as amelanotic/hypopigmented melanoma (AHM) and represent a challenge for early diagnosis. OBJECTIVES: Since the degree to which somatic mutations and copy number aberrations (CNA) in genes associated with skin-lightening or albinism may contribute to the loss of tumour pigmentation in AHM samples has not yet been addressed, we have investigated loss of function mutations of key pigmentation genes in matched germline and AHM as well as pigmented melanoma (PM) tumour DNA samples. METHODS: An analysis of clinical and histopathological characteristics together with whole exome sequencing data of 34 fresh frozen primary CM, graded according to the amount of pigmentation present was performed. Together with germline and somatic variant analysis, 30 samples were previously analysed for CNA changes. This study focussed on germline and somatic variants in the coding region of 16 genes known to be associated with albinism/hypopigmentation or variation in human pigmentation in all samples. Chromosomal regions encompassing these 16 genes were examined for DNA copy loss or gain. RESULTS: The finding that red hair related MC1R and TYR R402Q loss of activity gene variant alleles and genotypes are associated with AHM was validated in this study. Germline AHM-related gene variants were enriched in 70% (n=7 of 10) of AHM patients vs 8.3% (n=2 of 24) of PM patients. This surprisingly high frequency of rare germline variants in AHM patients constitutes the "first hit" and confirms that AHM patients are more likely to be albinism allele carriers than patients with PM. Next, in CNA analysis of each tumour sample, 50% (n=4 of 8) AHM samples with a pigmentation gene variant had LOH in the region containing the corresponding gene, and 25% (=2 of 8) had loss-of-heterozygosity (LOH) in chromosomal regions of two AHM-related genes. CONCLUSIONS: This study proposes that the likely molecular mechanism for development of amelanogenesis in AHM is carriage of an albinism/hypopigmentation allele followed by LOH of the corresponding gene in the tumour.
- Publisher
- Oxford Academic
- Research Division(s)
- Bioinformatics
- PubMed ID
- 39166481
- Publisher's Version
- https://doi.org/10.1093/bjd/ljae336
- Open Access at Publisher's Site
https://doi.org/10.1093/bjd/ljae336- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-08-23 02:54:08
Last Modified: 2024-08-23 02:56:30